IMR Press / CEOG / Volume 44 / Issue 6 / DOI: 10.12891/ceog3816.2017

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Paternal contribution to the preeclampsia phenotype
Show Less
1 Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan
Clin. Exp. Obstet. Gynecol. 2017, 44(6), 914–922;
Published: 10 December 2017

Purpose of investigation: The aims of this study were to elucidate functional pathways of genes responsible for key events in trophoblast invasion and to compare differences in paternal and maternal fitness gene expression in preeclampsia (PE) placenta. Materials and Methods: The authors combined data across seven studies published between 1995 and 2014. All genes downloaded from public web sites were analyzed using the metaprofiling and highlighted differentially expressed genes, the chromosomal location of the candidate genes, enriched pathways, and genomic conflicting situations that may play an important role in the trophoblast invasion. Results: The majority of differentially expressed genes and their downstream targets associated with trophoblast invasion were mediated through the activation of MMP signaling pathways. The paternal fitness genes that favor trophoblast invasion and fetal growth were reduced in the PE placenta. Half of the differentially expressed genes were located in close proximity to known imprinted genes. Several genes identified in PE were located in a cluster of imprinted genes on chromosomes 1p31, 9q34, and 11p15.4. Conclusion: PE may be recognized as a paternal/fetal imprinting disease.
Matrix metalloproteinase
Back to top